BISOPROLOL\HYDROCHLOROTHIAZIDE: 596 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
596
Total FAERS Reports
93 (15.6%)
Deaths Reported
287
Hospitalizations
596
As Primary/Secondary Suspect
55
Life-Threatening
18
Disabilities
Active Ingredient: BISOPROLOL FUMARATE\HYDROCHLOROTHIAZIDE ·
First Report: 19700101 · Latest Report: 20250401
What Are the Most Common BISOPROLOL\HYDROCHLOROTHIAZIDE Side Effects?
#1 Most Reported
Pruritus
82 reports (13.8%)
#2 Most Reported
Fall
75 reports (12.6%)
#3 Most Reported
Dizziness
67 reports (11.2%)
All BISOPROLOL\HYDROCHLOROTHIAZIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pruritus | 82 | 13.8% | 17 | 21 |
| Fall | 75 | 12.6% | 11 | 44 |
| Dizziness | 67 | 11.2% | 17 | 22 |
| Insomnia | 65 | 10.9% | 19 | 20 |
| Diarrhoea | 56 | 9.4% | 27 | 51 |
| Off label use | 55 | 9.2% | 1 | 15 |
| Asthenia | 54 | 9.1% | 20 | 33 |
| Vomiting | 54 | 9.1% | 20 | 47 |
| Erectile dysfunction | 53 | 8.9% | 0 | 1 |
| Bradycardia | 52 | 8.7% | 19 | 23 |
| Rash | 50 | 8.4% | 17 | 20 |
| Dyspnoea | 48 | 8.1% | 20 | 26 |
| Memory impairment | 48 | 8.1% | 15 | 21 |
| Nausea | 48 | 8.1% | 1 | 25 |
| Cataract | 46 | 7.7% | 19 | 19 |
| Nocturia | 46 | 7.7% | 19 | 19 |
| Anxiety | 45 | 7.6% | 0 | 0 |
| Headache | 45 | 7.6% | 0 | 0 |
| Acute kidney injury | 41 | 6.9% | 4 | 40 |
| Arthralgia | 41 | 6.9% | 19 | 19 |
Who Reports BISOPROLOL\HYDROCHLOROTHIAZIDE Side Effects? Age & Gender Data
Gender: 63.0% female, 37.0% male. Average age: 68.6 years. Most reports from: FR. View detailed demographics →
Is BISOPROLOL\HYDROCHLOROTHIAZIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 2 | 0 | 0 |
| 2003 | 1 | 0 | 1 |
| 2007 | 13 | 13 | 13 |
| 2008 | 13 | 12 | 12 |
| 2009 | 5 | 1 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 1 |
| 2012 | 2 | 0 | 0 |
| 2013 | 12 | 5 | 7 |
| 2014 | 16 | 3 | 3 |
| 2015 | 19 | 1 | 12 |
| 2016 | 27 | 2 | 13 |
| 2017 | 35 | 0 | 13 |
| 2018 | 76 | 5 | 34 |
| 2019 | 34 | 10 | 28 |
| 2020 | 33 | 9 | 17 |
| 2021 | 16 | 3 | 6 |
| 2022 | 10 | 0 | 4 |
| 2023 | 24 | 3 | 20 |
| 2024 | 6 | 1 | 6 |
| 2025 | 3 | 0 | 0 |
What Is BISOPROLOL\HYDROCHLOROTHIAZIDE Used For?
| Indication | Reports |
|---|---|
| Hypertension | 228 |
| Product used for unknown indication | 195 |
| Secondary progressive multiple sclerosis | 25 |
| Atrial fibrillation | 12 |
| Epilepsy | 9 |
| Blood pressure measurement | 7 |
| Tachycardia | 5 |
BISOPROLOL\HYDROCHLOROTHIAZIDE vs Alternatives: Which Is Safer?
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BIVALIRUDIN
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BLEOMYCIN
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BLINATUMOMAB
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BLONANSERIN
BISOPROLOL\HYDROCHLOROTHIAZIDE vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BOCEPREVIR
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BOCOCIZUMAB
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BONIVA
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BONVIVA
BISOPROLOL\HYDROCHLOROTHIAZIDE vs BORAGE OIL
Official FDA Label for BISOPROLOL\HYDROCHLOROTHIAZIDE
Official prescribing information from the FDA-approved drug label.